Light-based treatment of pediatric port-wine birthmarks

Jennifer M Tran1, Kristen M Kelly2, Beth A Drolet1

  • 1Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Pediatric Dermatology
|December 28, 2020
PubMed

Insights

Early light-based treatments, like pulsed dye laser, offer improved outcomes for pediatric port-wine birthmarks (PWBs). Understanding somatic mosaic mutations helps explain treatment variations in children versus adults.

Area of Science:

  • Dermatology
  • Vascular Malformations
  • Pediatric Medicine

Background:

  • Port-wine birthmarks (PWBs) are progressive vascular malformations causing disfigurement and psychosocial distress.
  • Somatic mosaic mutations are implicated in PWB progression and treatment response heterogeneity.
  • Pediatric PWBs exhibit distinct characteristics compared to adult cases, necessitating tailored treatment approaches.

Purpose of the Study:

  • To review pediatric-specific literature on light-based treatment modalities for port-wine birthmarks.
  • To provide guidance for pediatric dermatologists on indications, tips, advantages, and disadvantages of various treatments.

Main Methods:

  • Comprehensive literature review focusing on pediatric port-wine birthmark treatments.
  • Analysis of pulsed dye laser (PDL), near-infrared (NIR) lasers, and intense pulsed light (IPL) efficacy and safety.
  • Synthesis of clinical data regarding treatment parameters and outcomes in pediatric patients.

Main Results:

  • Early intervention with light-based therapies, particularly PDL, demonstrates superior outcomes in pediatric PWBs.
  • Heterogeneity in PWB vessel architecture and treatment response is observed in the pediatric population.
  • Specific advantages and disadvantages are identified for PDL, NIR lasers, and IPL in treating pediatric PWBs.

Conclusions:

  • Light-based treatments are effective for pediatric port-wine birthmarks, with early treatment being crucial.
  • Understanding the underlying genetic basis (somatic mosaic mutations) aids in predicting treatment response.
  • This review offers practical insights for pediatric dermatologists to optimize light-based PWB management.